financial statement as of 30 September 2017, the transaction size is of the highest value when calculated from net tangible asset test, which is equivalent to 14.48 per cent. According to the Notifications of
acquisition of shares from the existing shareholder (the “Share Acquisition Transaction”). Details of the Share Acquisition Transaction are as follows: 1. Subscription of 805,264 newly issued ordinary shares of
Type 2 Transaction (List 1). DOD Biotech Public Company Limited (the “Company”) hereby notifies the significant resolutions passed by the Board of Directors’ Meeting No. 8/2018, held on December 19, 2018
Mandatory Tender Offer by Using the Resolutions of Shareholders’ Meeting (Whitewash), Connected Transaction, Extension of Amount and Term of Bond Issuance, and Determination of Date of the Extraordinary
accordance with the Sale and Purchase Agreement as of March 20, 2018. The details of which are as follows: 1) Transaction Date 30 March 2018 2) Contractual Parties and Relationship with the Company Seller: U
means of subscription of newly issued shares of Hero Experience and acquisition of shares from the existing shareholder (the “Share Acquisition Transaction”. Details of the Share Acquisition Transaction
Connected transactions The Board of Director’s meeting of AEON Thana Sinsap (Thailand) Plc. No.10/2018 held on October 5, 2018 had a resolution of the connected transaction as follows: 1. Date of agreement
disposition of assets and connected transaction 2. POST 019/ 2019 dated 16 December 2019 Notification convening date of the Extraordinary General Meeting of Shareholders No. 1/2020 3. POST 003/2020 dated 3
would like to disclose information on the said transaction to the Stock Exchange of Thailand (“SET”) in accordance with the Acquisition or Disposal Notification as follows: 1. Date / Month / Year of the